• JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
 
  Bookmark and Share
 
 
Doctoral Thesis
DOI
https://doi.org/10.11606/T.5.2008.tde-14102008-144721
Document
Author
Full name
José Angelo Barletta Crescente
E-mail
Institute/School/College
Knowledge Area
Date of Defense
Published
São Paulo, 2008
Supervisor
Committee
Corbett, Carlos Eduardo Pereira (President)
Gomes, Claudia Maria de Castro
Laurenti, Marcia Dalastra
Silveira, Fernando Tobias
Strauss, Edna
Title in Portuguese
Estudo seccional sobre o espectro clínico e imunológico da infecção humana por Leishmania (L.) i. chagasi na Amazônia brasileira
Keywords in Portuguese
Epidemiologia
Espectro clínico-imunológico
Estudo seccional
Infecção humana
Leishmania (Leishmania) infantum chagasi
Abstract in Portuguese
A dinâmica da leishmaniose visceral humana na Amazônia brasileira é pouco conhecida e nos últimos anos tem aumentado a incidência da doença principalmente no Estado do Pará. Os objetivos do estudo foram: I) identificar indivíduos com infecção sintomática e/ou assintomática por Leishmania (L.) infantum chagasi, II) estudar os dois tipos de infecção, tanto clínica quanto imunologicamente, e III) estudar a taxa de prevalência da infecção. O estudo foi de corte transversal com 946 indivíduos de ambos os sexos, com idade a partir de 1 ano, vivendo em área endêmica de leishmaniose visceral americana (LVA), município de Barcarena, Pará, Brasil. Para o diagnóstico da infecção, foram usadas a reação dérmica de hipersensibilidade retardada (Reação Intradérmica de Montenegro) - RIM e a Reação de Imunofluorêscencia Indireta (RIFI). Foram diagnosticados 120 casos de infecção com taxa de prevalência de 12.6%; 8 casos mostraram alta soro-reatividade (1.280 a 120.240) IgG utilizando-se o teste da RIFI e nenhuma reação na RIM; 4 casos foram típicos de LVA e outros 4 casos de infecção subclínica oligossintomática. Os dois métodos imunológicos usados simultaneamente com o exame clínico permitiram a identificação de 5 perfis clínico-imunológicos: Infecção Assintomática (IA) 73,4%; Infecção Subclínica Resistente(ISR) 15%; Infecção Subclínica Oligossintomática (ISO) 3%; Infecção Sintomática (IS=LVA) 3% e, Infecção Inicial Indeterminada (III) 5%
Title in English
A cross study on the clinical and immunological spectrum of human Leishmania (L.) i. chagasi infection in the Brazilian amazon
Keywords in English
Clinical and immunological spectrum
Cross-sectional studies
Epidemiology
Human infection
Leishmania(L.) infantum chagasi
Abstract in English
The dynamic of the human visceral leishmaniasis in the Amazon region is not well known and the incidence of the diseases in the last years have increase mainly in the Para state. The objectives the study were I) to identify individuals with symptomatic and/or asymptomatic infection due to Leishmania (L.) i. chagasi, II) to study the two types of infection, both clinically and immunologically, and III) to study the prevalence rate of infection. This was a cross-sectional study with a cohort of 946 individuals, of both sexes, with age from one year old onward, living in an endemic area of American Visceral Leishmaniasis (AVL), municipality of Barcarena, Pará State, Brazil. For the diagnosis of infection, the delayed hypersensitivity skin reaction (LST) and the indirect fluorescent antibody test (IFAT) were used. One hundred twenty cases of infection were diagnosed, with a prevalence rate of 12.6%; 8 cases showed high seroreactivity (1.280 to 10.240, IgG) in IFAT and no reaction in the LST; 4 cases being of typical AVL and other 4 cases of subclinical oligosymptomatic infection. The two immunological methods used simultaneously, with the clinical examination enabled to identify 5 clinical-immunological profiles: Asymptomatic Infection (AI) 73.4%; Subclinical Resistant Infection (SRI) 15%; Subclinical Oligosymptomatic Infection (SOI) 3%; Symptomatic Infection (SI=AVL) 3% and, Indeterminate Initial Infection (III) 5%
 
WARNING - Viewing this document is conditioned on your acceptance of the following terms of use:
This document is only for private use for research and teaching activities. Reproduction for commercial use is forbidden. This rights cover the whole data about this document as well as its contents. Any uses or copies of this document in whole or in part must include the author's name.
joseabcrescente.pdf (13.96 Mbytes)
Publishing Date
2008-11-07
 
WARNING: Learn what derived works are clicking here.
All rights of the thesis/dissertation are from the authors
CeTI-SC/STI
Digital Library of Theses and Dissertations of USP. Copyright © 2001-2024. All rights reserved.